Chapter 1. Market Scope and Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Companion Diagnostics Market, by Technology
1.4.2 North America Companion Diagnostics Market, by Indication
1.4.3 North America Companion Diagnostics Market, by Cancer Type
1.4.4 North America Companion Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Companion Diagnostics Market by Technology
3.1 North America Immunohistochemistry Market by Country
3.1.1 North America Polymerase chain reaction (PCR) Market by Country
3.1.2 North America Next generation sequencing (NGS) Market by Country
3.1.3 North America In Situ Hybridization Market by Country
3.1.4 North America Other Technology Market by Country
Chapter 4. North America Companion Diagnostics Market by Indication
4.1 North America Oncology Companion Diagnostics Market by Country
4.2 North America Neurology Companion Diagnostics Market by Country
4.3 North America Other Indications Companion Diagnostics Market by Country
Chapter 5. North America Companion Diagnostics Market by Cancer Type
5.1 North America Breast Cancer Companion Diagnostics by Country
5.2 North America Colorectal Cancer Companion Diagnostics by Country
5.3 North America Lung Cancer Companion Diagnostics by Country
5.4 North America Blood Cancer Companion Diagnostics by Country
5.5 North America Other Cancer Type Companion Diagnostics Market by Country
Chapter 6. North America Companion Diagnostics Market by Country
6.1 USA Companion Diagnostics Market
6.1.1 USA Companion Diagnostics Market by Technology
6.1.2 USA Companion Diagnostics Market by Indication
6.1.2.1 USA Companion Diagnostics Market by Cancer Type
6.2 Canada Companion Diagnostics Market
6.2.1 Canada Companion Diagnostics Market by Technology
6.2.2 Canada Companion Diagnostics Market by Indication
6.2.2.1 Canada Companion Diagnostics Market by Cancer Type
6.3 Mexico Companion Diagnostics Market
6.3.1 Mexico Companion Diagnostics Market by Technology
6.3.2 Mexico Companion Diagnostics Market by Indication
6.3.2.1 Mexico Companion Diagnostics Market by Cancer Type
6.4 Rest of North America Companion Diagnostics Market
6.4.1 Rest of North America Companion Diagnostics Market by Technology
6.4.2 Rest of North America Companion Diagnostics Market by Indication
6.4.2.1 Rest of North America Companion Diagnostics Market by Cancer Type
Chapter 7. Company Profiles
7.1 Agilent Technologies, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research and Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product launches:
7.1.5.2 Expansions:
7.2 Almac Group
7.2.1 Company Overview
7.2.1 Recent strategies and developments:
7.2.1.1 Collaborations, partnerships and agreements:
7.3 ARUP Laboratories, Inc.
7.3.1 Company Overview
7.4 Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research and Development Expense
7.5 Danaher Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research and Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research and Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Expansions:
7.7 Hologic, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research and Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.7.5.2 Acquisition and mergers:
7.8 Novartis AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research and Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Illumina, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research and Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Acquisition and mergers:
7.9.5.3 Collaborations, partnerships and agreements:
7.1 Qiagen N.V.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research and Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product launches:
7.10.5.2 Collaborations, partnerships and agreements:
Unique Offerings 
